Changes to Havrix booster dose

Changes to the prescribing information for the Havrix Monodose hepatitis A vaccine mean that it is no longer necessary to restart the primary vaccination schedule if the booster is administered within five years of primary vaccination.

Although a booster dose is normally recommended between six to 12 months of primary vaccination, it has been shown that immunocompetent subjects given a booster up to five years after initial vaccination can show a satisfactory antibody response sufficient for persistent immunity.

Further information: GlaxoSmithKline, Stockley Park West, Uxbridge, Middlesex UB11 1BT. Tel: (0800) 221441.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more